55 related articles for article (PubMed ID: 6109496)
1. [Pharmacology of nitroglycerin].
Meistelman C; Deligné P
Ann Anesthesiol Fr; 1980; 21(2):185-95. PubMed ID: 6109496
[No Abstract] [Full Text] [Related]
2. Comparing the role of glutathione-S-transferase and mitochondrial aldehyde dehydrogenase in nitroglycerin biotransformation and the correlation with calcitonin gene-related peptide.
Zhang XJ; Chang L; Zhang YM; Deng S; Li YJ; Peng J
Eur J Pharmacol; 2009 Sep; 617(1-3):97-101. PubMed ID: 19576883
[TBL] [Abstract][Full Text] [Related]
3. Absence of metabolite formation during nitroglycerin-induced relaxation of isolated blood vessels.
Armstrong JA; Marks GS; Armstrong PW
Mol Pharmacol; 1980 Jul; 18(1):112-6. PubMed ID: 6774227
[No Abstract] [Full Text] [Related]
4. Studies of the bioavailability of nitroglycerin from a transdermal therapeutic system (Nitroderm TTS).
Imhof PR; Vuillemin T; Gérardin A; Racine A; Müller P; Follath F
Eur J Clin Pharmacol; 1984; 27(1):7-12. PubMed ID: 6436032
[TBL] [Abstract][Full Text] [Related]
5. Bioactivation of nitroglycerin to nitric oxide (NO) and S-nitrosothiols in the rat liver and evaluation of the coexisting hypotensive effect.
Sokołowska M; Bednarski M; Kwiecień I; Filipek B; Włodek L
Fundam Clin Pharmacol; 2004 Aug; 18(4):449-56. PubMed ID: 15312151
[TBL] [Abstract][Full Text] [Related]
6. Intravenous nitroglycerin: new uses for an old drug.
Spector R
J Iowa Med Soc; 1983 Mar; 73(3):96-99. PubMed ID: 6404995
[No Abstract] [Full Text] [Related]
7. [Oxidative stress in nitroglycerin tolerance and treatment with 3,4,5,6-tetrahydroxyxanthone].
Shi RZ; Zhang GG; Bai YP; Li YJ; Hu GY; Chen J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 31(5):650-4. PubMed ID: 17062923
[TBL] [Abstract][Full Text] [Related]
8. Effect of angiotensin converting enzyme inhibitors on tolerance of nitroglycerin.
Fang Z; Li Y; Liu D; Li Y; Hao F; Liu Z
Chin Med J (Engl); 1995 Dec; 108(12):919-22. PubMed ID: 8728945
[TBL] [Abstract][Full Text] [Related]
9. Nitroglycerin-mediated S-nitrosylation of proteins: a field comes full cycle.
Stamler JS
Circ Res; 2008 Sep; 103(6):557-9. PubMed ID: 18796638
[No Abstract] [Full Text] [Related]
10. [Pharmacokinetics and relative bioavailability of a nitroglycerin ointment formulation (author's transl)].
Maier-Lenz H; Ringwelski L; Windorfer A
Arzneimittelforschung; 1980; 30(2):320-4. PubMed ID: 6769443
[TBL] [Abstract][Full Text] [Related]
11. Reversal of tolerance to nitroglycerin with vinpocetine: a role of calcitonin gene-related peptide.
Nie SD; Hu CP; Chen YR; Wang S; Deng HW; Li YJ
Int J Cardiol; 2008 Apr; 125(3):436-8. PubMed ID: 17804099
[TBL] [Abstract][Full Text] [Related]
12. [The nitric oxide system in a chronic deficiency of mesostriatal dopamine: the action of nitroglycerin].
Sahach VF; Baziliuk OV; Oleshko MM; Kotsiuruba OV; Bukhanevych OM; Appenzeller O
Fiziol Zh (1994); 2000; 46(2):55-63. PubMed ID: 10867863
[TBL] [Abstract][Full Text] [Related]
13. [The effect of nitroglycerin on the pharmacological properties of strophanthin in experiments in vitro and in vivo].
Sergeev PV; Galenko-Iaroshevskiĭ PA; Lemkina SM; Kostin IaV
Biull Eksp Biol Med; 1995 Apr; 119(4):387-90. PubMed ID: 7620136
[No Abstract] [Full Text] [Related]
14. Bioactivation of nitroglycerin and vasomotor response to nitric oxide are impaired in cirrhotic rat livers.
Dudenhoefer AA; Loureiro-Silva MR; Cadelina GW; Gupta T; Groszmann RJ
Hepatology; 2002 Aug; 36(2):381-5. PubMed ID: 12143046
[TBL] [Abstract][Full Text] [Related]
15. Intravenous nitroglycerin: a review.
Baaske DM; Yacobi A; Amann AH
Am Pharm; 1982 Feb; NS22(2):36-9. PubMed ID: 6800249
[No Abstract] [Full Text] [Related]
16. Pharmacokinetic interaction between 5-[2-propyloxy-5-(1-methyl-2-pyrollidinylethylamidosulfonyl)phenyl]-1-methyl-3-propyl-1,6-dihydro-7H-pyrazolo (4,3-d) pyrimidine-7-one (DA-8159) and nitroglycerin in rats.
Lee SJ; Bae SK; Kwon JW; You M; Lee DC; Lee MG
J Pharm Pharmacol; 2005 Nov; 57(11):1397-405. PubMed ID: 16259771
[TBL] [Abstract][Full Text] [Related]
17. Nitroglycerin ointment for angina pectoris.
Med Lett Drugs Ther; 1981 Sep; 23(19):82-3. PubMed ID: 6792478
[No Abstract] [Full Text] [Related]
18. Relaxant properties mediated by nitroglycerin in aortic coarctation hypertensive rats.
Ogawa Y; Okumura K; Matsui H; Fukami Y; Saburi Y; Iami H; Mizuno T; Nishimoto Y
Heart Vessels; 2002 Dec; 17(2):69-73. PubMed ID: 12541097
[TBL] [Abstract][Full Text] [Related]
19. Portal-systemic shunting and the hemodynamic effects of nitroglycerin in the rat.
Blei AT; O'Reilly DJ; Gottstein J
Gastroenterology; 1984 Jun; 86(6):1428-36. PubMed ID: 6425103
[TBL] [Abstract][Full Text] [Related]
20. Nitroglycerin and the neuromuscular blockade produced by gallamine, succinylcholine, d-tubocurarine, and pancuronium.
Glisson SN; Sanchez MM; El-Etr AA; Lim RA
Anesth Analg; 1980 Feb; 59(2):117-22. PubMed ID: 6768318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
